Remgro, the legendary investment holding company controlled by the Rupert family, has been a stalwart in the SPW Equity portfolio for many years. The share has outperformed the JSE All Share Index by about 35% since the unbundling of British American Tobacco (BAT) in October 2008, contributing positively towards the outperformance of the portfolio.
Nearly 80% of the value of Remgro is made up by JSE-listed companies, including Mediclinic (30%), FirstRand and RMB Holdings (RMBH) (23%), RMI Holdings (13%), Distell (6%), RCL Foods (6%) and smaller contributions by Grindrod and eMedia. The major unlisted investments in the Remgro stable include Unilever SA (7%), Air Products (3%) and Community Investment Holdings (CIVH), which owns 51% of Dark Fibre Africa (3% of Remgro’s value).
It’s theoretically possible to replicate 80% of the Remgro portfolio by investing directly in the underlying listed shares. However, by buying Remgro, you’re investing in this basket of shares indirectly at a 17% discount to their current market values. On the other hand, you’re giving up the flexibility to be more selective about the actual shares you’d like to own as well as the relative position sizing (if you buy Remgro, you have to take the basket as is). The Remgro management team also retain a portion of the dividends and reinvest this as they see fit, either creating or destroying value in the process.
We thought it might be an interesting exercise to consider how a buy-and-hold strategy in terms of Remgro’s listed shares would have fared compared to the reported Remgro net asset value (NAV) since March 2009 (first reporting date after the BAT unbundling). If we assume that the unlisted Remgro rump and all subsequent cash flows were reinvested in line with the market, we calculate that the Remgro portfolio would have grown from R47.6 billion in March 2009 to R161.7 billion by December 2016, taking Remgro dividends into account. Remgro’s actual NAV at end-2016 amounted to R152.9 billion – or R8.8 billion below the theoretical buy-and-hold strategy.
About R4 billion of this can be ascribed to the timing of the Mediclinic/Al Noor merger in terms of which Remgro increased its stake in the group, while around R2 billion can be attributed to holding company expenses over the eight-year period. The remaining R2.7 billion is the net effect of other transactions executed by Remgro management, notably the sale of Nampak and unbundling of Implats and Trans Hex, which all added relative value to shareholders. These were offset by further investments in RCL Foods and the acquisition of Grindrod, which in turn detracted from relative performance to date.
The sale of RMI and RMBH shares in 2012 to facilitate the Royal Bafokeng empowerment transaction were also major transactions during the period. Both RMI and RMBH continued to perform strongly after 2012.
We continue to see Remgro as a good long-term investment for private investors’ share portfolios given a diversified set of quality assets as well as an attractive discount to NAV. However, tax implications aside, with 80% of the underlying assets currently available for direct investment in a more flexible way, an active asset manager may question the investment merit of Remgro versus a higher-conviction direct approach on the underlying assets.
For the moment, the relatively high discount to NAV and attractive valuation on some of the key listed assets justifies holding Remgro in the SPW Equity portfolio. Should the discount narrow, however, we may advocate switching a portion of Remgro into some of the underlying assets that we prefer. This, we believe, should enhance prospective returns for our investors.
Comparison of total returns – Remgro and its underlying assets:
We can assist you with
Discretionary investment management
Sanlam Private Wealth manages a comprehensive range of multi-asset (balanced) and equity portfolios across different risk categories.
Our team of world-class professionals can design a personalised offshore investment strategy to help diversify your portfolio.
Our customised Shariah portfolios combine our investment expertise with the wisdom of an independent Shariah board comprising senior Ulama.
Outsourced investment service
We collaborate with third-party providers to offer collective investments, private equity, hedge funds and structured products.
Sanlam Private Wealth (Pty) Ltd, registration number 2000/023234/07, is a licensed Financial Services Provider (FSP 37473), a registered Credit Provider (NCRCP1867) and a member of the Johannesburg Stock Exchange (‘SPW’).
All reasonable steps have been taken to ensure that the information on this website is accurate. The information does not constitute financial advice as contemplated in terms of FAIS. Professional financial advice should always be sought before making an investment decision.
Participation in Sanlam Private Wealth Portfolios is a medium to long-term investment. The value of portfolios is subject to fluctuation and past performance is not a guide to future performance. Calculations are based on a lump sum investment with gross income reinvested on the ex-dividend date. The net of fee calculation assumes a 1.15% annual management charge and total trading costs of 1% (both inclusive of VAT) on the actual portfolio turnover. Actual investment performance will differ based on the fees applicable, the actual investment date and the date of reinvestment of income. A schedule of fees and maximum commissions is available upon request.
COLLECTIVE INVESTMENT SCHEMES
The Sanlam Group is a full member of the Association for Savings and Investment SA. Collective investment schemes are generally medium to long-term investments. Past performance is not a guide to future performance, and the value of investments / units / unit trusts may go down as well as up. A schedule of fees and charges and maximum commissions is available on request from the manager, Sanlam Collective Investments (RF) Pty Ltd, a registered and approved manager in collective investment schemes in securities (‘Manager’).
Collective investments are traded at ruling prices and can engage in borrowing and scrip lending. The manager does not provide any guarantee either with respect to the capital or the return of a portfolio. Collective investments are calculated on a net asset value basis, which is the total market value of all assets in a portfolio including any income accruals and less any deductible expenses such as audit fees, brokerage and service fees. Actual investment performance of a portfolio and an investor will differ depending on the initial fees applicable, the actual investment date, date of reinvestment of income and dividend withholding tax. Forward pricing is used.
The performance of portfolios depend on the underlying assets and variable market factors. Performance is based on NAV to NAV calculations with income reinvestments done on the ex-dividend date. Portfolios may invest in other unit trusts which levy their own fees and may result is a higher fee structure for Sanlam Private Wealth’s portfolios.
All portfolio options presented are approved collective investment schemes in terms of Collective Investment Schemes Control Act, No. 45 of 2002. Funds may from time to time invest in foreign countries and may have risks regarding liquidity, the repatriation of funds, political and macroeconomic situations, foreign exchange, tax, settlement, and the availability of information. The manager may close any portfolio to new investors in order to ensure efficient management according to applicable mandates.
The management of portfolios may be outsourced to financial services providers authorised in terms of FAIS.
TREATING CUSTOMERS FAIRLY (TCF)
As a business, Sanlam Private Wealth is committed to the principles of TCF, practicing a specific business philosophy that is based on client-centricity and treating customers fairly. Clients can be confident that TCF is central to what Sanlam Private Wealth does and can be reassured that Sanlam Private Wealth has a holistic wealth management product offering that is tailored to clients’ needs, and service that is of a professional standard.